In this study, we aimed to explore ZRF1’s role in breast cancer progression in a more elaborate way and performed experiments in both ER (+) (MCF7, T47D) and ER (–) (MDA-MB-231, MDA-MB-453) cell lines. Here, DNAJC2 is linked to breast carcinoma.